Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.280
-0.240 (-9.52%)
At close: Nov 7, 2025, 4:00 PM EST
2.290
+0.010 (0.44%)
After-hours: Nov 7, 2025, 7:18 PM EST
Neuronetics Market Cap
Neuronetics has a market cap or net worth of $156.15 million as of November 7, 2025. Its market cap has increased by 430.05% in one year.
Market Cap
156.15M
Enterprise Value
218.93M
1-Year Change
430.05%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $464.84M to $156.15M, a decrease of -66.41%. That is a compound annual growth rate of -13.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 156.15M | 74.27% |
| Dec 31, 2024 | 89.60M | 6.79% |
| Dec 29, 2023 | 83.91M | -55.13% |
| Dec 30, 2022 | 187.01M | 59.02% |
| Dec 31, 2021 | 117.60M | -44.22% |
| Dec 31, 2020 | 210.82M | 151.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |